Novonesis A/s Class B · OMXCOP:NSIS_B
Novonesis A/s Class B — Novozymes — FY2015 Earnings Presentation
8 slides from Novonesis A/s Class B's earnings presentation, Jan 19, 2016
Slide 1: Conference call FY 2015
Conference call FY 2015 January 19, 2016
Slide 2: Forward-Looking Statements
Forward-Looking Statements This presentation and its related comments contain forward-looking statements, including statements about future events, future financial performance, plans, strategies and expectations. Forward-looking statements are associated with words such as, but not limited to, "be
Slide 3: 2015 Summary
2015 Summary Solid financial results; strong earnings Sales and organic growth 2013-2015 on moderate sales growth DKKm • 4% organic sales growth driven by Agriculture & Feed and Food & 10% 15,000 Beverages. 12% growth in DKK. 2% organic sales growth in Q4 8% 7% 7% 14,000 14,002 • Challenging market
Slide 4: U.S. biofuels – a slow-growth industry
U.S. Ethanol Production Bioenergy Sales, USD 160 U.S. biofuels – a slow-growth industry 140 • 14.8 billion gallons of ethanol produced by the U.S. ethanol industry in 2015*, up ~3% 120 • U.S. ethanol production grew by 2% per year on Index (2010 = 100) average from 2010 to 2015. Novozymes’ global Bi
Slide 5: Household Care market remains attractive despite challenging 2015
Household Care market remains attractive despite challenging 2015 Unique negative events in 2015 not deemed systemic • One customer reducing spend on specific enzymes • Latin America weak due to currencies and macro Sales growth to improve in 2016 as we work through challenges; growth skewed toward
Slide 6: Sales & markets
Sales & markets Full-year 2015 sales: DKK +12%, organic +4% Sales by industry, DKKm DKK growth /org. growth Q4 2015 sales: DKK +9%, organic +2% Household 4,632 Household Care: Strong growth from a number of important customers Care 4,353 +6% / +1% across markets offset by a challenging Latin Ameri
Slide 7: Pipeline of significant market-expanding growth opportunities
Pipeline of significant market-expanding growth opportunities On top of the flow of innovation to existing markets, Novozymes is currently investing in innovation to expand the market for enzyme and microbial technology. Each of the innovation clusters below can potentially make a significant posit
Slide 8: Financial performance & outlook
Financial performance & outlook 2015: Strong earnings performance • EBIT grew by close to 20%. EBIT margin expanded by ~1.5 %- Key Realized 2016 outlook points on a like-for-like basis Jan. 19 financials 2015 • Gross margin up 0.7 %-point due to productivity improvements and lower raw material pric